Precision Tracking of Samples Enabled at Low Temperatures
|
By LabMedica International staff writers Posted on 28 Feb 2012 |

Image: Each vial is tagged with a unique RFID identifier. The RFID tag is integrated into the vial – it cannot be removed, or fall off inadvertently (Photo courtesy of Biotillion).
A new solution enables real-time (RT) precision tracking of samples in situ at low temperatures.
Difficulties in tracking samples are due to the inability to locate automatically the samples, as well as a lack of robust connection between the physical sample and archiving software. The task is further complicated at ultra low temperatures.
The ColdTrack platform was designed to solve these problems. The platform enables electronic tracking by associating a unique electronic tag with each sample, enabling fast mapping of sample boxes.
Tens of millions of new biological samples are collected and stored annually by pharmaceutic companies, universities, hospitals, diagnostic testing and research centers, national genetic databases, and forensic laboratories.
BioTillion (Skillman, NJ, USA), a privately held company, introduced the ColdTrack platform at the SLAS 2012 meeting in San Diego (CA, USA), which was held in February 2012.
Each ColdTrack sample vial has unique radio frequency identification (RFID) tag that cannot be changed or replicated in another, and contains user-defined data that may be modified by a user. The RFID-tagged vials survive exposure to a wide range of temperatures: from liquid nitrogen temperatures (-196 °C) up to the maximum operating temperature of the vial (121 °C) without loss of data or functionality.
A freezer box is mapped by placing the box containing one or more ColdTrack vials on a BoxMapper. The BoxMapper can map the contents of an 81-sample freezer box in about a second. The reader is connected to a computer using a USB cable.
The BoxMapper is integrated with a group of laboratory information-management systems (LIMS) packages. The details of the CDR-LIMS interaction is slightly different for each LIMS package but in all cases the box contents are transferred to the LIMS program automatically so that the user does not need to enter vial IDs or box locations.
Related Links:
BioTillion
SLAS 2012 meeting
Difficulties in tracking samples are due to the inability to locate automatically the samples, as well as a lack of robust connection between the physical sample and archiving software. The task is further complicated at ultra low temperatures.
The ColdTrack platform was designed to solve these problems. The platform enables electronic tracking by associating a unique electronic tag with each sample, enabling fast mapping of sample boxes.
Tens of millions of new biological samples are collected and stored annually by pharmaceutic companies, universities, hospitals, diagnostic testing and research centers, national genetic databases, and forensic laboratories.
BioTillion (Skillman, NJ, USA), a privately held company, introduced the ColdTrack platform at the SLAS 2012 meeting in San Diego (CA, USA), which was held in February 2012.
Each ColdTrack sample vial has unique radio frequency identification (RFID) tag that cannot be changed or replicated in another, and contains user-defined data that may be modified by a user. The RFID-tagged vials survive exposure to a wide range of temperatures: from liquid nitrogen temperatures (-196 °C) up to the maximum operating temperature of the vial (121 °C) without loss of data or functionality.
A freezer box is mapped by placing the box containing one or more ColdTrack vials on a BoxMapper. The BoxMapper can map the contents of an 81-sample freezer box in about a second. The reader is connected to a computer using a USB cable.
The BoxMapper is integrated with a group of laboratory information-management systems (LIMS) packages. The details of the CDR-LIMS interaction is slightly different for each LIMS package but in all cases the box contents are transferred to the LIMS program automatically so that the user does not need to enter vial IDs or box locations.
Related Links:
BioTillion
SLAS 2012 meeting
Latest Technology News
- Point-of-Care Testing Enhances Health Literacy and Self-Management in Chronic Disease
- Fully Automated Sample-to-Insight Workflow Advances Latent TB Testing
- Tumor-on-a-Chip Platform Models Pancreatic Cancer Treatment Response
- New Platform Captures Extracellular Vesicles for Early Cancer Detection
- Microfluidic Single-Cell Assay Predicts Breast Cancer Risk
- AI Tool Predicts Non-Response to Targeted Therapy in Colorectal Cancer
- Integrated System Streamlines Pre-Analytical Workflow for Molecular Testing
- Noninvasive Sputum Test Detects Early Lung Cancer
- New AI Tool Enables Rapid Treatment Selection in Pediatric Leukemia
- Rapid Biosensor Detects Drug Sensitivity in Breast Tumors
- Breakthrough Mass Spectrometry Design Could Enable Ultra-Low Abundance Detection
- Online Tool Supports Family Screening for Inherited Cancer Risk
- Portable Breath Sensor Detects Pneumonia Biomarkers in Minutes
- New Electronic Pipette Enhances Workflows with Touchscreen Control
- AI Model Outperforms Clinicians in Rare Disease Detection
- AI-Driven Diagnostic Demonstrates High Accuracy in Detecting Periprosthetic Joint Infection
Channels
Clinical Chemistry
view channel
Urine-Based Nanosensor Tracks Lung Cancer and Fibrosis Noninvasively
Lung cancer remains difficult to monitor for early progression and treatment resistance, while pulmonary fibrosis continues to pose major challenges for early diagnosis. Clinicians need repeatable, noninvasive... Read more
Blood-Based Alzheimer’s Test Gains CE Mark for Amyloid Pathology Detection
Alzheimer’s disease is the most common cause of dementia, yet confirmatory testing remains invasive and hard to access. Diagnosis currently takes an average of 3.5 years, and about 75% of people with dementia... Read moreMolecular Diagnostics
view channel
Sensitive Protein Marker Aids Diagnosis of Small Cell Prostate Cancer
Accurate identification of aggressive prostate cancer subtypes can be difficult when tumors lose expression of lineage markers used in routine pathology. Small cell carcinoma of the prostate, in particular,... Read more
Rapid Multiplex PCR Test Detects 11 Gastrointestinal Pathogens from Single Sample
Cepheid’s Xpert GI Panel has received CE marking under the In Vitro Diagnostic Medical Devices Regulation (IVDR) and is expected to begin shipping to countries that accept the CE mark in the coming weeks.... Read moreHematology
view channel
Stem Cell Biomarkers May Guide Precision Treatment in Acute Myeloid Leukemia
Acute myeloid leukemia (AML) is an aggressive blood cancer that most often affects older adults and still carries a poor prognosis despite therapeutic advances. Venetoclax-based regimens have improved... Read more
Advanced CBC-Derived Indices Integrated into Hematology Platforms
Diatron, a STRATEC brand, has introduced six advanced hematological indices on its Aquila, Aquarius 3, and Abacus 5 hematology analyzers. The new Research Use Only (RUO) indices include Neutrophil-to-Lymphocyte... Read moreImmunology
view channel
Routine TB Screening Test May Reveal Immune Aging and Mortality Risk
Immune aging is associated with weaker responses to vaccination, greater risks of infection, and higher levels of inflammation. Leveraging routinely ordered laboratory tests to quantify that responsiveness... Read more
Biomarkers and Molecular Testing Advance Precision Allergy Care
Allergic diseases often present with similar symptoms but can be driven by distinct biological mechanisms, making standardized care inefficient for many patients. Historically, individuals with pollen... Read moreMicrobiology
view channel
Study Finds Hidden Mpox Infections May Drive Ongoing Spread
Mpox continues to circulate despite vaccination, and many cases show no known link to a symptomatic partner. The role of people without symptoms has remained uncertain, limiting clarity on how transmission persists.... Read more
Large-Scale Genomic Surveillance Tracks Resistant Bacteria Across European Hospitals
Antimicrobial resistance (AMR) poses a growing threat to patient safety, with carbapenem-resistant Enterobacterales causing difficult-to-treat infections and leaving clinicians with limited therapeutic options.... Read more
Molecular Urine and Stool Tests Do Not Improve Early TB Treatment in Hospitalized HIV Patients
Tuberculosis is the leading cause of death among people living with HIV, and diagnosis in hospital settings remains difficult. Symptoms are often non-specific, disease can be extrapulmonary, and many patients... Read morePathology
view channel
FDA Clears AI Digital Pathology Tool for Breast Cancer Risk Stratification
Risk assessment at diagnosis is central to guiding therapy for early-stage, hormone receptor-positive, human epidermal growth factor receptor 2-negative (HR+/HER2-) invasive breast cancer, where overtreatment... Read more
New AI Tool Reveals Hidden Genetic Signals in Routine H&E Slides
Pathologists worldwide rely on hematoxylin and eosin (H&E) slides to examine tissue architecture, yet these stains do not reveal the underlying molecular activity that often drives disease.... Read moreIndustry
view channel
AI-Powered Multi-Functional Analyzer Wins German Innovation Award
Hematology services are increasingly delivered across distributed care settings, where limited staffing and complex workflows can extend turnaround times. Advanced morphology review still often depends... Read more








